Moderna says Health Canada has approved its mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and ...

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target of £14.50. The company’s shares closed yesterday at ...

As AstraZeneca’s chronic obstructive pulmonary disease drug Breztri continues climbing toward blockbuster status, the Big Pharma is broadening its efforts to support people with COPD. | As AstraZeneca ...

In a report released today, Rajan Sharma from Goldman Sachs maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a ...

We will deliver our fully reinvigorated portfolio to market efficiently and maximise the considerable commercial potential, ...

European markets are heading for a negative open Wednesday, as investors await the latest growth data from the region and ...

European markets are heading for a negative open Wednesday, as investors await the latest growth data from the region and ...

London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves ...

That’s what tends to happen following any positive news on this share. "Drugmaker GSK said on Thursday that new data for its respiratory syncytial virus vaccine showed potential to help protect ...

News for GlaxoSmithKline Consumer Healthcare Ltd. HUL Faces Rs 963 Cr Income Tax Demand: Appeal Planned Hindustan Unilever (HUL) received a Rs 963 crore Income Tax demand for non-deduction of TDS on ...